OncoMatch/Clinical Trials/NCT04770207
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Is NCT04770207 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Injection of drug-eluting microspheres with multiple drugs into solid tumors for hepatocellular carcinoma.
Treatment: Injection of drug-eluting microspheres with multiple drugs into solid tumors — To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Hepatocellular Carcinoma
Tumor Agnostic
Demographics
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT04770207 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 99 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages